Physician profile
Richard V Chua
NPI 1356334528
$1,285,920.00
in general payments reported to CMS, 2019-2025
21 companies · $121K in 2025
The $121K reported for 2025 was more than what 98% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97K · 2020: $214K · 2021: $337K · 2022: $262K · 2023: $165K · 2024: $88K · 2025: $121K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $294K · Consulting Fee: $45K · Travel and Lodging: $27K · Food and Beverage: $9,522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $294,387.50 |
| Consulting Fee | $44,512.50 |
| Travel and Lodging | $26,746.60 |
| Food and Beverage | $9,522.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $972,763.08 | 2021-2025 | Mazor X System, Pivox Oblique Lateral Spinal System, Stealthstation S8 Platform |
| Medtronic USA, INC. | $310,736.06 | 2019-2020 | |
| Orthofix Medical, INC. | $366.24 | 2019-2025 | Firebird, Lattus, Alloquent S |
| Nuvasive, INC. | $352.75 | 2019-2021 | |
| Globus Medical, INC. | $304.25 | 2024-2025 | Excelsius Deformity, Omnia |
| Stryker Corporation | $277.64 | 2022-2024 | Universal Neuro 3 |
| Arteriocyte Medical Systems, INC. | $168.81 | 2024 | Magellan |
| Medacta USA, INC. | $138.52 | 2023 | Myspine |
| Si-Bone, INC. | $114.28 | 2022 | |
| Brainlab, INC. | $103.52 | 2022 | |
| Bioventus LLC | $102.67 | 2022 | |
| Providence Medical Technology, INC. | $102.33 | 2021-2025 | |
| Spineology INC. | $81.02 | 2022 | |
| Carlsmed, INC. | $63.38 | 2022 | |
| Abbott Laboratories | $56.98 | 2021-2025 | Infinity, Eterna |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Augmedics INC. | $46.86 | 2020-2025 | Xvision |
| Nevro Corp. | $39.70 | 2019-2021 | |
| Boston Scientific Corporation | $36.49 | 2025 | Wavewriter Alpha Prime 16 |
| Arbor Pharmaceuticals, INC. | $23.10 | 2021 | |
| Depuy Synthes Sales INC. | $22.46 | 2025 | Teligen, Trialtis, Symphony |
| Kls-Martin L.P. | $19.86 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Chua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.